FDA proposes to pull liquid statin FloLipid from market
The FDA is proposing to withdraw the liquid formulation of simvastatin, known as FloLipid, from the market after Salerno Pharmaceuticals failed to file required annual reports, according to a Nov. 18 notice in the Federal Register. The FDA annual reports convey labeling information and technicalities, including updates on labeling and on chemistry, manufacturing and controls, […] The post FDA proposes to pull liquid statin FloLipid from market appeared first on Becker's Hospital Revie...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.